Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The ‘run-in part’ primary objective: • To determine a safe light dose for PC-A11 with interstitial laser light application in patients with recurrent head and neck squamous cell carcinoma unsuitable for surgery and radiotherapy and eligible for interstitial laser light application. The ‘expansion part’ primary objective: • To assess the efficacy of PC-A11 with superficial and/or interstitial laser light application in patients with recurrent SCCHN by means of local non-progression rates at 6 months.
Inclusion criteria
- Recurrent head and neck squamous cell carcinoma (HNSCC) insuitable for surgery and radiotherapy